Isozyme-specific fluorescent inhibitor of glutathione s-transferase omega 1

ACS Chemical Biology
|March 9, 2010
PubMed

Insights

A novel fluorescent compound specifically inhibits and monitors glutathione S-transferase omega 1 (GSTO1) activity. This tool aids research into GSTO1

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Chemical Biology

Background:

  • Glutathione S-transferase omega 1 (GSTO1) involvement in diseases like cancer and neurodegeneration is suspected.
  • Investigating GSTO1's pathological roles is challenging due to a lack of specific activity-monitoring tools, especially in the presence of similar enzyme isoforms.

Discussion:

  • A newly developed fluorescent compound (compound 6) specifically targets and inhibits GSTO1's active site.
  • Compound 6 achieves inhibition through covalent modification, crucially sparing other GST isoforms.
  • This compound enables the monitoring of GSTO1 activity in cellular systems (HEK293, NIH/3T3) via fluorescence detection.

Key Insights:

  • Compound 6 acts as a specific inhibitor for GSTO1.
  • Compound 6 functions as a reporter for GSTO1 activity.
  • The compound's specificity allows for precise study of GSTO1 in complex biological samples.

Outlook:

  • Compound 6 offers a valuable tool for advancing research into GSTO1's function in health and disease.
  • Further applications may include drug discovery targeting GSTO1-related pathologies.
  • This development facilitates deeper understanding of GSTO1's role in cancer and neurodegenerative disease pathways.